Jaana E Martikainen

Summary

Affiliation: Social Insurance Institution
Country: Finland

Publications

  1. ncbi Adoption of new antiglaucoma drugs in Finland: impact of changes in copayment
    Jaana E Martikainen
    Research Department, The Social Insurance Institution, Helsinki, Finland
    Clin Ther 29:2468-76. 2007
  2. ncbi European prices of newly launched reimbursable pharmaceuticals--a pilot study
    Jaana Martikainen
    Research Department, The Social Insurance Institution, P O Box 450, FIN 00101 Helsinki, Finland
    Health Policy 74:235-46. 2005
  3. ncbi New chemical entities and their market penetration in Finland during the years 1996 through 2005
    Jaana E Martikainen
    Research Department, The Social Insurance Institution, Helsinki, Finland
    Clin Ther 31:668-76. 2009
  4. ncbi Impact of restricted reimbursement on the use of statins in Finland: a register-based study
    Jaana E Martikainen
    Research Department, The Social Insurance Institution, Helsinki, Finland
    Med Care 48:761-6. 2010
  5. ncbi Antipsychotics and antidepressants: an analysis of cost growth in Finland from 1999 to 2005
    Hanna Koskinen
    Research Department, The Social Insurance Institution, Helsinki, Finland
    Clin Ther 31:1469-77. 2009
  6. ncbi At-risk patients still predisposed for myocardial infarction by coxibs
    Arja Helin-Salmivaara
    Eur J Clin Pharmacol 63:97-8. 2007

Detail Information

Publications6

  1. ncbi Adoption of new antiglaucoma drugs in Finland: impact of changes in copayment
    Jaana E Martikainen
    Research Department, The Social Insurance Institution, Helsinki, Finland
    Clin Ther 29:2468-76. 2007
    ..In Finland, new antiglaucoma drugs start with a high copayment, but once sufficient clinical experience is available, they are reevaluated and can receive a lower copayment status...
  2. ncbi European prices of newly launched reimbursable pharmaceuticals--a pilot study
    Jaana Martikainen
    Research Department, The Social Insurance Institution, P O Box 450, FIN 00101 Helsinki, Finland
    Health Policy 74:235-46. 2005
    ..Wholesale prices were highest in those countries where manufacturers are free to set the prices of their products. Pharmacy margins and taxes, however, change the ranking of the most expensive or the cheapest countries...
  3. ncbi New chemical entities and their market penetration in Finland during the years 1996 through 2005
    Jaana E Martikainen
    Research Department, The Social Insurance Institution, Helsinki, Finland
    Clin Ther 31:668-76. 2009
    ..There is little empirical information about the role of new chemical entities (NCEs) and to what extent they are being adopted in modern health care...
  4. ncbi Impact of restricted reimbursement on the use of statins in Finland: a register-based study
    Jaana E Martikainen
    Research Department, The Social Insurance Institution, Helsinki, Finland
    Med Care 48:761-6. 2010
    ..This study investigated the short-term consequences of the restricted reimbursement of expensive statins (atorvastatin and rosuvastatin) on the use of statins in Finland...
  5. ncbi Antipsychotics and antidepressants: an analysis of cost growth in Finland from 1999 to 2005
    Hanna Koskinen
    Research Department, The Social Insurance Institution, Helsinki, Finland
    Clin Ther 31:1469-77. 2009
    ..Antipsychotics and antidepressants are among the fastest-growing therapeutic classes, but the reasons behind recent cost growth are not clear...
  6. ncbi At-risk patients still predisposed for myocardial infarction by coxibs
    Arja Helin-Salmivaara
    Eur J Clin Pharmacol 63:97-8. 2007